Discover

NRXP
NRx Pharmaceuticals, Inc.
3.40
5 x 3.20
1 x 3.47
bid
ask
+
0.05
1.49%
1 @ 04:00 PM
3.46 +0.06 (1.65%)
Ytd25.46%
1y46.55%
3.35
day range
3.40
1.62
52 week range
5.05
Open3.39Prev Close3.35Low3.35High3.40Mkt Cap58.77M
Vol1.17MAvg Vol1.28MEPS-0.37P/E-9.19Forward P/E-1.12
Beta1.27Short Ratio4.80Inst. Own6.05%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg3.89200-d Avg2.781yr Est31.67

NRXP News

NRx Pharmaceuticals, Inc. (NRXP) Discusses FDA First Cycle Review Outcome and Commercialization Plans for Preservative Free Ketamine Transcript
seekingalpha.com
NRx Pharmaceuticals, Inc. (NRXP) Discusses FDA First Cycle Review Outcome and Commercialization Plan

NRx Pharmaceuticals, Inc. (NRXP) Discusses FDA First Cycle Review Outcome and Commercialization Plan

NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles
marketbeat.com
NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles

NRx Pharmaceuticals NASDAQ: NRXP said it has completed the first-cycle U.S. Food and Drug Administra

benzinga.com
NRx Pharmaceuticals To Host Conference Call And Q&A Session On August 10 To Discuss FDA's Completion

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx Pharmaceuticals", the "Company"), a cl

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
globenewswire.com
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle

MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceutic

benzinga.com
BTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10

BTIG analyst Thomas Shrader maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and lowers the

benzinga.com
NRx Pharmaceuticals Announces FDA Found No Major Deficiencies In Its First-Cycle Review Of ANDA For

No major deficiencies related to the drug product, ingredients, proposed labeling, Chemistry, Manufa

FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
globenewswire.com
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Defic

FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed lab

12 Health Care Stocks Moving In Friday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock increased by 91.1% to $6.04 during Friday's

NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
globenewswire.com
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx”

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
globenewswire.com
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Sur

First Zeta-navigated TMS treatments have begun at HOPE Therapeutics clinics in West Palm Beach and S

Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition
businesswire.com
Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Bre

SAN DIEGO--(BUSINESS WIRE)--Kadima Neuropsychiatry Institute and its founder, Dr. David Feifel, have

ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics
prnewswire.com
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HO

SARASOTA, Fla, and BOSTON, June 23, 2026 /PRNewswire/ -- ZETA SURGICAL and HOPE Therapeutics, an NRx

NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression
globenewswire.com
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based N

WILMINGTON, Del., June 22, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a biop

NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology.
globenewswire.com
NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nas

MIAMI, June 05, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (Nasdaq:NRXP, “the Company”) announces

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters' Option
globenewswire.com
NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Inc

Offering was led by B Group Capital with significant participation from, among others, Columbia Thre

NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
globenewswire.com
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

WILMINGTON, Del., June 03, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx P

12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

Tetra Technologies Inc. (NYSE: TTI) shares fell 15.06% in pre-market trading after announcing a $100

NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
globenewswire.com
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

WILMINGTON, Del., June 02, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx P

NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validation of the EMOCARE Depression Thermometer at ASCP 2026
globenewswire.com
NRx Pharmaceuticals (Nasdaq: NRXP) Strategic Partner Emobot Presents Late-Breaking Clinical Validati

EMOCARE is a smartphone-based passive monitoring tool that generates a continuous, real-time measure

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
globenewswire.com
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Dep

Deployment at HOPE's West Palm Beach clinic brings AI-powered, sub-millimetric image guidance to the

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

My Top 3 Biotech Stocks for May 2026
fool.com
My Top 3 Biotech Stocks for May 2026

As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, se

NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty
seekingalpha.com
NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty

NRx Pharmaceuticals (NRXP) is downgraded from 'Buy' to 'Sell' following failures in ZYESAMI and NRX-

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
seekingalpha.com
NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

NRx Pharmaceuticals Q1 Earnings Call Highlights
marketbeat.com
NRx Pharmaceuticals Q1 Earnings Call Highlights

NRx Pharmaceuticals NASDAQ: NRXP said it advanced several regulatory, manufacturing and clinical ini

NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
NRx Pharmaceuticals (Nasdaq:NRXP) Reports First Quarter 2026 Financial Results and Provides Corporat

Key highlights from the first quarter of operations under the expanded management team include the f

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Earnings Scheduled For November 17, 2025
benzinga.com
Earnings Scheduled For November 17, 2025

benzinga.com
Earnings Scheduled For May 15, 2025

benzinga.com
Earnings Scheduled For March 17, 2025

Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply in today's pre-market trading.

benzinga.com
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In T

benzinga.com
Earnings Scheduled For March 28, 2024

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quart

benzinga.com
Earnings Scheduled For November 14, 2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  Friday's session saw 225 companies set new 52-week lows.

benzinga.com
Earnings Scheduled For August 14, 2023

Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report q

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  During Tuesday's trading, 188 companies set new 52-week lows.

benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga.com
Earnings Scheduled For March 30, 2023

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quart

benzinga.com
Earnings Scheduled For November 14, 2022

Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly

benzinga.com
Why Lottery.com Shares Are Trading Lower By 59%? 54 Stocks Moving In Friday's Mid-Day Session

Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.

benzinga.com
Why Amazon Is Trading Higher By 12%: Here Are 23 Stocks Moving Premarket

Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.

benzinga.com
Why Meta Platforms Is Trading Lower By More Than 6%: Here Are 34 Stocks Moving Premarket

Gainers JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the c

benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022

Upgrades

benzinga.com
Stocks That Hit 52-Week Lows On Wednesday

  On Wednesday, 807 companies reached new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Tuesday

  Tuesday's session saw 211 companies set new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Thursday

  During Thursday, 849 stocks hit new 52-week lows.

benzinga.com
Stocks That Hit 52-Week Lows On Friday

  On Friday, 431 companies hit new 52-week lows.